Back

Cycloheximide BioChemica

Assay (HPLC): min. 98 %
Code
A0879
CAS
66-81-9
Molecular Formula
C15H23NO4
Molar mass
281.36 g/mol

Recommended prices only. To see your prices login or contact your local distributor.
Box prices only valid with purchase of full box.

code packaging size price per unit box price per unit
Code & packaging Price per piece
A0879,0600
code
A0879,0600
packaging size
600 g
price per unit
single Request a quote
box price per unit
A0879,0001
code
A0879,0001
packaging size
1 g
price per unit
single 72,80€
box price per unit
A0879,0005
code
A0879,0005
packaging size
5 g
price per unit
single 244,20€
box price per unit
A0879,0025
code
A0879,0025
packaging size
25 g
price per unit
single 1023,10€
box price per unit
A0879,0100
code
A0879,0100
packaging size
100 g
price per unit
single 4083,30€
box price per unit
Solubility:
21 g/L (H2O)
Physical Description:
Solid
Product Code:
A0879
Product Name:
Cycloheximide BioChemica
Specifications:
Assay (HPLC): min. 98 %
α20°C/D; 1 %, CHCl3: -26° - -32°
Hazard pictograms
  • GHS06 Hazard
  • GHS08 Hazard
  • GHS09 Hazard
UN:
2811
Class/PG:
6.1/I
ADR:
6.1/I
IMDG:
6.1/I
IATA:
6.1/I
WGK:
3
Storage:
RT
Signal Word:
Danger
GHS Symbols:
GHS06
GHS08
GHS09
H Phrases:
H300
H341
H360D
H411
P Phrases:
P280
P301+P310
P321
P330
P405
P501
EINECS:
200-636-0
CS:
29419000
Index Nr.:
613-140-00-8
Download TDS file for complete specifications

FAQs

What is the CAS number of Cycloheximide ?

The CAS number of Cycloheximide is 66-81-9.

CAS Cycloheximide ?

The CAS number of Cycloheximide is 66-81-9.

CAS 66-81-9?

The CAS number 66-81-9 is assigned to Cycloheximide .

Literature

(1) Obrig, T.G. et al. (1971) J. Biol. Chem. 246, 174-181. The mechanism by which cycloheximide and related glutarimide antibiotics inhibit peptide synthesis in reticulocyte ribosomes. (2) Wilson, T. & Treisman, R. (1988) Nature 336, 396-399. Removal of poly(A) and consequent degradation of c-fos - mRNA facilitated by 3' AU-rich sequences. (3) Subramaniam, M. et al. (1989) Nature 340, 64-66. Negative regulation of serum-responsive enhancer elements.